Concepedia

Author

Gayle Jameson

Translational Genomics Research InstituteORCID

Also Known As

G. Jameson, G. S. Jameson, G.S. Jameson, Gayle Jameson, Gayle S Jameson, Gayle S. Jameson, Jameson, G., Jameson, Gayle S.

136

Publications

3.5K

Citations

23

H-Index

61

Concepts

All Affiliations

Translational Genomics Research InstituteHonorHealthMayo Clinic in ArizonaComprehensive Cancer Centers of NevadaMayo Clinic Hospital
GJ

About

Gayle Jameson is an author at Translational Genomics Research Institute specializing in medicine, cancer therapeutics, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

21

2.4K

2

Health Sciences

7

7

801

3

Emergency Medicine

2

2

64

4

Gastroenterology

1

1

20

5

Hepatology

1

1

20

Gayle Jameson

×

35

Publications

3.3K

Citations

23

H-Index

YearCitations

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky,

The Lancet

2015

1.2K

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

Daniel D. Von Hoff, Joseph J. Stephenson, Peter J. Rosen,

Journal of Clinical Oncology

2010

628

Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions

Wei Lin, Pawan Noel, Erkut Borazanci,

Genome Medicine

2020

320

Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study

Ramesh K. Ramanathan, Ronald L. Korn, Natarajan Raghunand,

Clinical Cancer Research

2017

171

A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer

Gayle Jameson, Emanuel F. Petricoin, Jasgit C. Sachdev,

Breast Cancer Research and Treatment

2014

82

First-in-human trial of novel oral PARP inhibitor BMN 673 in patients with solid tumors.

Johann S. de Bono, Lida A. Mina, Michael Gonzalez,

Journal of Clinical Oncology

2013

75

Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study

Brian G. Czito, Dustin A. Deming, Gayle Jameson,

˜The œLancet. Gastroenterology & hepatology

2017

74

Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer

Gayle Jameson, Erkut Borazanci, Hani M. Babiker,

JAMA Oncology

2019

71

Skeletal metastases in pancreatic cancer: a retrospective study and review of the literature.

Mitesh J. Borad, Hamid Saadati, Arun Lakshmipathy,

Europe PMC (PubMed Central)

2009

60

A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors

Gayle Jameson, John Hamm, Glen J. Weiss,

Clinical Cancer Research

2012

53

Page 1